Europe Canada Oncology Market Access & Pricing Director Are you ready to shape regional access and pricing strategies that get transformative cancer medicines to patients faster across Europe and Canada (EUCAN)? In this role, you will steer regional
About This Role: As the Lead Value and Access for Switzerland and Austria, you will play a pivotal role in designing and implementing strategies to maximize the value recognition of our drug portfolio among payors. You will
What its about A Senior Auditorspecialized inData & AIbridges deep technical expertise with internal audit practice, using data, AI, and modern tooling to sharpen risk identification, surface anomalies, and elevate the quality of audit insights. This
About This Role The PO&T Commercial Asset Development Leader is a member of the Asset Development & Portfolio Management (ADPM) team which provides cross-functional guidance across PO&T’s line functions for commercial assets. The role oversees and
Global Medical Director, Evidence Generation Lead About This Role: As the Global Medical Director, Evidence Generation Lead, you will play a pivotal role in advancing data generation initiatives for Dravet Syndrome therapeutic area. This position resides
Regional Franchise Head Oncology Europe Canada (EUCAN) Join a place that’s working to fundamentally change the way cancer is treated. Evolving to an outcomes-based model – we go beyond treatment to shape the cancer care environment
Europe Canada Oncology Market Access & Pricing Director Are you ready to shape regional access and pricing strategies that get transformative cancer medicines to patients faster across Europe and Canada(EUCAN)? In this role, you will steer regional strategy
Europe Canada Oncology Market Access & Pricing DirectorAre you ready to shape regional access and pricing strategies that get transformative cancer medicines to patients faster across Europe and Canada (EUCAN)?In this role, you will steer regional strategy and
About This Role: As the I-CoE Medical Director for SMA, you will be based in Baar, Switzerland, and lead medical initiatives within the International Center of Excellence (I-CoE). This role is pivotal in shaping the medical
About This RoleThe PO&T Commercial Asset Development Leader is a member of the Asset Development & Portfolio Management (ADPM) team which provides cross‑functional guidance across PO&T’s line functions for commercial assets. The role oversees and owns
Global Medical Director, Evidence Generation LeadAbout This Role: As the Global Medical Director, Evidence Generation Lead, you will play a pivotal role in advancing data generation initiatives for the Dravet Syndrome therapeutic area. This position resides
Regional Franchise Head Oncology Europe Canada (EUCAN) Join a place that’s working to fundamentally change the way cancer is treated. Evolving to an outcomes‑based model – we go beyond treatment to shape the cancer care environment
What its about The Portfolio Management business unit is responsible for the strategic steering and portfolio management of the private market investment mandates of Partners Group. The group furthermore supports the acquisition & retention of institutional
Key Account Manager – CVRM Region Central Switzerland – AstraZeneca AG Switzerland This role will be 100% field‑based – German‑speaking part of Switzerland Who are we looking for? Are you motivated to play a key role
Data & Predictive Sciences will only be successful by working in close collaboration with Research Technologies, Therapy Areas, GSK Tech, AIML, Vaccines, Risk &Compliance, and across lines within the functionitself, and by developing and fostering a high-performing
Data & Predictive Sciences will only be successful by working in close collaboration with Research Technologies, Therapy Areas, GSK Tech, AIML, Vaccines, Risk &Compliance, and across lines within the functionitself, and by developing and fostering a high-performing
Regional Franchise Head Oncology Europe Canada (EUCAN) Join a place that’s working to fundamentally change the way cancer is treated. Evolving to an outcomes-based model – we go beyond treatment to shape the cancer care environment